title: [Surfactant replacement therapy increases life-span of patients with acute respiratory distress syndrome].
abstract: The aim of the study is the evaluation of the influence of surfactant replacement therapy on the life-span of patients with acute respiratory distress syndrome (ARDS) in fatal cases. It has been determined, that in patients, were died from ARDS, exogenous surfactant therapy increases life-span from the moment of establishing of diagnosis of syndrome to fatal outcome. The initial functional state of lungs does not influence on life-span of patients with ARDS, but administration of exogenous surfactant is the important predictor of its increase.
authors.forename: A L
authors.initials: AL
authors.lastname: Potapov
authors.forename: N Iu
authors.initials: NIu
authors.lastname: Novikov
authors.forename: V A
authors.initials: VA
authors.lastname: Tumanskiĭ
authors.forename: A A
authors.initials: AA
authors.lastname: Babanin
mesh_terms: D000328:Adult; D005260:Female; D006801:Humans; D007322:Instillation, Drug; D007442:Intubation, Intratracheal; D008168:Lung / Q000187:drug effects* / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D011663:Pulmonary Surfactants / Q000494:pharmacology / Q000627:therapeutic use*; D012128:Respiratory Distress Syndrome / Q000188:drug therapy* / Q000401:mortality / Q000503:physiopathology; D012129:Respiratory Function Tests; D012189:Retrospective Studies; D016019:Survival Analysis
chemical_list: D011663:Pulmonary Surfactants